🇺🇸 FDA
Pipeline program

[177Lu]-NeoB solution for infusion, AAA503

CAAA603A12101

Phase 2 small_molecule active

Quick answer

[177Lu]-NeoB solution for infusion, AAA503 for Solid tumors known to overexpress GRPR and with [68Ga]-NeoB lesion uptake. is a Phase 2 program (small_molecule) at Advanced Accelerator Applications with 1 ClinicalTrials.gov record(s).

Program details

Company
Advanced Accelerator Applications
Indication
Solid tumors known to overexpress GRPR and with [68Ga]-NeoB lesion uptake.
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials